Atlas Trials

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

Clinical trial NCT04922008 · UNKNOWN

Trial details

NCT number
NCT04922008
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-07-01
Primary completion
2024-06-30
Enrollment
356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.